These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1351152)

  • 41. Haemolytic disease of the newborn due to antibodies other than rhesus anti-D.
    Br Med J (Clin Res Ed); 1981 Aug; 283(6290):514-5. PubMed ID: 6790046
    [No Abstract]   [Full Text] [Related]  

  • 42. Immunoglobulins in haemolytic disease of the newborn.
    McKay E; Thom H
    Biol Neonate; 1973; 23(3):214-22. PubMed ID: 4204178
    [No Abstract]   [Full Text] [Related]  

  • 43. Monocyte monolayer assay (MMA)--an efficient method for predicting the clinical significance of alloantibodies and the severity of hemolytic disease of the newborn.
    Garratty G
    Beitr Infusionsther; 1988; 21():236-9. PubMed ID: 2462981
    [No Abstract]   [Full Text] [Related]  

  • 44. [Frequency and significance of leucocyte iso-antibodies in women with Rh-incompatibility (author's transl)A1].
    Hübel E; Bertrams J; Kuwert E; Luboldt W; Fischer K
    Z Immunitatsforsch Exp Klin Immunol; 1972 May; 143(4):411-8. PubMed ID: 4282923
    [No Abstract]   [Full Text] [Related]  

  • 45. [Lan antigen of erythrocytes and clinical significance of anti-Lan antibody].
    Kuśnierz-Alejska G; Wiecek B
    Acta Haematol Pol; 1993; 24(2):169-75. PubMed ID: 8372617
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hemolytic disease of the newborn due to rare maternal alloantibodies (7 years of experience)].
    Zuliani G; Moroni GA; Buscaglia M; Baudino G; Nardini J; Pardi G
    Ann Ostet Ginecol Med Perinat; 1983; 104(1):42-52. PubMed ID: 6859734
    [No Abstract]   [Full Text] [Related]  

  • 47. A descriptive single-centre experience of the management and outcome of maternal alloantibodies in pregnancy.
    Chatziantoniou V; Heeney N; Maggs T; Rozette C; Fountain C; Watts T; Harrison C; Pasupathy D; Sankaran S; Kyle P; Robinson S
    Transfus Med; 2017 Aug; 27(4):275-285. PubMed ID: 28608631
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of immunoglobulin G human leukocyte antigen-specific alloantibodies in renal transplant patients using single-antigen-beads is compromised by the presence of immunoglobulin M human leukocyte antigen-specific alloantibodies.
    Kosmoliaptsis V; Bradley JA; Peacock S; Chaudhry AN; Taylor CJ
    Transplantation; 2009 Mar; 87(6):813-20. PubMed ID: 19300182
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Management of feto-maternal red cell allo-immunizations].
    Bricca P; Guinchard E; Guitton Bliem C
    Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rh immunoglobulin in prevention of hemolytic disease of newborn child.
    Gorman JG
    N Y State J Med; 1983 Jan; 83(1):42-9. PubMed ID: 6402737
    [No Abstract]   [Full Text] [Related]  

  • 51. Assessment of severity of haemolytic disease of newborn by monocyte monolayer assay.
    Dhingra-Kumar N; Duguid JK; Bromilow IM
    Indian J Med Res; 1995 Aug; 102():71-6. PubMed ID: 8834817
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An example of anti-s causing mild haemolytic disease of the newborn.
    Davie MJ; Smith DS; White UM; Dyball D
    J Clin Pathol; 1972 Sep; 25(9):772-3. PubMed ID: 5086219
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distribution of IgG subtypes in maternal anti-D sera and their prognostic value in Rh haemolytic disease of the new-born.
    Iyer YS; Kulkarni SV; Gupte SC
    Acta Haematol; 1992; 88(2-3):78-81. PubMed ID: 1466203
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Haemolytic disease of the newborn caused by anti-MUT (MNS 35).
    van den Bos AG; Steiner K
    Vox Sang; 2004 Oct; 87(3):208-9. PubMed ID: 15569075
    [No Abstract]   [Full Text] [Related]  

  • 55. ABO haemolytic disease of the newborn: laboratory prediction and post-natal diagnosis.
    Lockyer WJ
    Med Lab Sci; 1982 Jul; 39(3):287-95. PubMed ID: 6752621
    [No Abstract]   [Full Text] [Related]  

  • 56. Letter: Inactivation of IgM antibodies.
    Davey MG
    Vox Sang; 1976; 31(2):160. PubMed ID: 951975
    [No Abstract]   [Full Text] [Related]  

  • 57. Direct antiglobulin reaction in ABO-haemolytic disease of the newborn.
    Romano EL; Hughes-Jones NC; Mollison PL
    Br Med J; 1973 Mar; 1(5852):524-6. PubMed ID: 4540300
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alloantibodies and platelet destruction.
    Klein CA; Blajchman MA
    Semin Thromb Hemost; 1982 Apr; 8(2):105-15. PubMed ID: 7043738
    [No Abstract]   [Full Text] [Related]  

  • 59. Hemolytic disease of the newborn due to combination of anti-E and anti-S in the first pregnancy.
    Kanra T; Tunçer M; Pirnar A
    Turk J Pediatr; 1983; 25(1):49-54. PubMed ID: 6417855
    [No Abstract]   [Full Text] [Related]  

  • 60. Monocyte monolayer assay, autoanalyser values, and haemolytic disease of the newborn.
    Bromilow IM; Duguid JK
    Br J Haematol; 1991 Aug; 78(4):588. PubMed ID: 1911360
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.